Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction-Reference-Cited by-同舟云学术

Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction

Published:2013-08 Issue:3 Volume:167 Page:1027-1037
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Campbell Duncan J.,Somaratne Jithendra B.,Jenkins Alicia J.,Prior David L.,Yii Michael,Kenny James F.,Newcomb Andrew E.,Kelly Darren J.,Black Mary Jane

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?;Lerman;Eur Heart J,2007

2. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction;Uren;N Engl J Med,1994

3. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease;Uren;J Am Coll Cardiol,1993

4. Alteration in regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography;Sambuceti;Am J Cardiol,1993

5. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity;Beanlands;J Am Coll Cardiol,1995

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole blood transcriptome profile at hospital admission discriminates between patients with ST-segment elevation and non-ST-segment elevation acute myocardial infarction;Scientific Reports;2020-05-26

2. Copper promotion of myocardial regeneration;Experimental Biology and Medicine;2020-03-08

3. Endostatin predicts mortality in patients with acute dyspnea – A cohort study of patients seeking care in emergency departments;Clinical Biochemistry;2020-01

4. Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study;Atherosclerosis;2019-05

5. Obesity and its cardiovascular effects;Diabetes/Metabolism Research and Reviews;2019-02-20